Ole Haagen Nielsen

31PUBLICATIONS
112CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)Agricultural biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Dec 12, 2025
Heterogeneity of the intestinal mononuclear phagocyte compartment in health and inflammatory bowel disease.

Thomas M Fenton, Line Wulff, Venla Väänänen

|Dec 11, 2025
Fibroblast diversity within human gut-associated lymphoid tissues.

Urs M Mörbe, Fredrik V Junghus, Grigorii Nos

|Dec 17, 2024
Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial.

Luc Biedermann, Michael Doulberis, Philipp Schreiner

|Nov 12, 2024
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations.

Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth

|Oct 28, 2024
Microfibrillar-associated protein 4 as a predictive biomarker of treatment response in patients with chronic inflammatory diseases initiating biologics: secondary analyses based on the prospective BELIEVE cohort study.

Bjørk K Sofíudóttir, Heidi L Munk, Robin Christensen

|Aug 20, 2024
In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis.

Mohamed Attauabi, Johan Burisch, Ole Haagen Nielsen

Pageof 6

Frequent Collaborators

6 joint publications

John Mark Gubatan

3 joint publications

Fredrik Olof Bergenheim

3 joint publications

Lene Buhl Riis

3 joint publications

Peter B Jørgensen